Evidence map›Paper›PMID 30882674›Full record

Observational studyMedicine2019

Association between BDNF Val66Met polymorphism and generalized anxiety disorder and clinical characteristics in a Mexican population: A case-control study.

Thelma Beatriz González-Castro, Sherezada Pool-García, Carlos Alfonso Tovilla-Zárate, Isela Esther Juárez-Rojop, María Lilia López-Narváez, Ana Frésan, Alma Delia Genis-Mendoza, Nonanzit Pérez-Hernández, Humberto Nicolini

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. The Role of Long Non-Coding RNA in Anxiety Disorders: A Literature Review.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Associations between methamphetamine use disorder andDialogues in clinical neuroscience · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Thelma Beatriz González-CastroDivisión Académica Multidisciplinaria de Jalpa de Méndez, Universidad Juárez Autónoma de Tabasco, Jalpa de Méndez, Tabasco, México.
Sherezada Pool-GarcíaHospital General de Comalcalco, Secretaría de Salud, Comalcalco, Tabasco, México.
Carlos Alfonso Tovilla-ZárateDivisión Académica Multidisciplinaria de Comalcalco, Universidad Juárez Autónoma de Tabasco, Comalcalco, Tabasco, México.
Isela Esther Juárez-RojopDivisión Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco, Villahermosa, Tabasco, México.
María Lilia López-NarváezHospital General de Yajalón "Dr. Manuel Velazco Suarez", Secretaría de Salud, Yajalón, Chiapas, México.
Ana FrésanSubdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, México.
Alma Delia Genis-MendozaServicios de Atención Psiquiátrica (SAP), Instituto Nacional de Medicina Genómica (INMEGEN), Ciudad de México, México.
Nonanzit Pérez-HernándezDepartamento de Biología Molecular, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.
Humberto NicoliniServicios de Atención Psiquiátrica (SAP), Instituto Nacional de Medicina Genómica (INMEGEN), Ciudad de México, México.
Universidad Juárez Autónoma de Tabasco · MXNational Institute of Genomic Medicine · MXSecretaria de Salud · HNInstituto Nacional de Cardiología · MXInstituto Nacional de Psiquiatría · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present case-control study was to explore the association between BDNF Val66Met (rs6265) polymorphism and generalized anxiety disorder in Mexican individuals, and whether this polymorphism plays a role in the symptomatology of anxiety.A total of 212 subjects were included in the study. Around 75 patients with generalized anxiety disorder were diagnosed by psychiatrists based on the DSM-IV instrument and 137 unrelated subjects psychiatrically healthy were used as comparison group. The subclinical symptomatology in patients was assessed with the State-Trait Anxiety Inventory. BDNF rs6265 genotypes were analyzed using the polymerase chain reaction end-point method.The association between BDNF Val66Met with the risk for generalized anxiety disorder was evaluated using 4 inheritance models. The present study showed that carrying the Met allele confers increased risk for the presence of generalized anxiety disorder (χ = 4.7, P = .03; OR (95%) 1.96 (1.05-3.56)) when patients with generalized anxiety disorder were compared with the comparison group.Our results provide evidence of an association between the Val66Met polymorphism of the BDNF gene and generalized anxiety disorder in a Mexican population. However, no association was observed between this polymorphism and the symptomatology of anxiety.

Indexed as

Anxiety DisordersAdultBehavioral SymptomsBrain-Derived Neurotrophic FactorCorrelation of DataDiagnostic and Statistical Manual of Mental DisordersFemaleGenetic Predisposition to DiseaseHumansMaleMexicoMiddle AgedPolymorphism, Single NucleotidePsychiatric Status Rating ScalesBDNF protein, humanBrain-Derived Neurotrophic Factor

Identifiers

PMID30882674
PMCPMC6426483
OpenAlexW2920924933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.